Cargando…

A randomized and comparative study to assess safety and efficacy of supplemental treatment of a herbal formulation - Aayudh Advance comprising essential oils in patients with corona virus 2019 (COVID-19)

OBJECTIVE: The purpose of this study was to examine the effect of herbal formulation - Aayudh Advance on viral load as well as recovery duration in mild symptomatic patients diagnosed with Corona Virus Disease 2019 (COVID-19). It also aimed to study the effect of Herbal formulation – Aayudh Advance...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutt, Jayesh, Ganatra, Bhavdeep, Suthar, Nilay, Malek, Mohammedebrahim, Shukla, Bhakti, Shukla, Krupali, Shukla, Karna, Pandit, Shreya, Rachchh, Manish, Gokani, Rina, Bhalani, Mona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948525/
https://www.ncbi.nlm.nih.gov/pubmed/33728385
http://dx.doi.org/10.1016/j.conctc.2021.100755
_version_ 1783663427129966592
author Dutt, Jayesh
Ganatra, Bhavdeep
Suthar, Nilay
Malek, Mohammedebrahim
Shukla, Bhakti
Shukla, Krupali
Shukla, Karna
Pandit, Shreya
Rachchh, Manish
Gokani, Rina
Bhalani, Mona
author_facet Dutt, Jayesh
Ganatra, Bhavdeep
Suthar, Nilay
Malek, Mohammedebrahim
Shukla, Bhakti
Shukla, Krupali
Shukla, Karna
Pandit, Shreya
Rachchh, Manish
Gokani, Rina
Bhalani, Mona
author_sort Dutt, Jayesh
collection PubMed
description OBJECTIVE: The purpose of this study was to examine the effect of herbal formulation - Aayudh Advance on viral load as well as recovery duration in mild symptomatic patients diagnosed with Corona Virus Disease 2019 (COVID-19). It also aimed to study the effect of Herbal formulation – Aayudh Advance in terms of clinical improvement of various sign and symptoms in mild symptomatic COVID-19 patients. METHOD: Once the patient suffice the requirement of inclusion, exclusion criteria of the study than as per the method of ‘Covariate Adaptive Randomization’ technique, patient was assigned in either Aayudh Advance arm (Test arm) or Control Arm. Here standard of Care treatment was given to all patients of both the arms. Treatment was given for the period of 14 days or till patient turned COVID-19 negative, which ever was earlier. Clinical signs and symptoms viz. body temperature, SpO 2, Scoring of Cough & Scoring of Shortness of breath were recorded on all 5 Clinical visits along with biochemical testing like RT-PCR (with CT value of E gene and RDRP gene), serum ferritin, CRP and NLR observed on weekly Visit. RESULT: Total 74 patients were enrolled in the present study. Out of which 60 patients (30 patients in each group) have completed study as per the protocol, whereas 14 patients have voluntarily withdrawn from the study due to getting early discharge from the hospital. All patients in Aayudh Advance treatment group recovered (100%) after 14 days. This observed recovery was 15.38% more as compared to Standard of Care treatment alone. Further, there was statistically significant reduction (p < 0.05) in viral load as indicated by significant increase in CT value of E-gene and RDRP gene. Further, no patients reported any Adverse Reaction as well as no drug to drug interaction was observed with supplemental treatment with Aayudh Advance. CONCLUSION: The Aayudh Advance was found safe as well as more effective in terms of reduction of viral load. % recovery was more in Treatment arm as compared to Control arm in mild symptomatic COVID-19 patients.
format Online
Article
Text
id pubmed-7948525
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-79485252021-03-11 A randomized and comparative study to assess safety and efficacy of supplemental treatment of a herbal formulation - Aayudh Advance comprising essential oils in patients with corona virus 2019 (COVID-19) Dutt, Jayesh Ganatra, Bhavdeep Suthar, Nilay Malek, Mohammedebrahim Shukla, Bhakti Shukla, Krupali Shukla, Karna Pandit, Shreya Rachchh, Manish Gokani, Rina Bhalani, Mona Contemp Clin Trials Commun Article OBJECTIVE: The purpose of this study was to examine the effect of herbal formulation - Aayudh Advance on viral load as well as recovery duration in mild symptomatic patients diagnosed with Corona Virus Disease 2019 (COVID-19). It also aimed to study the effect of Herbal formulation – Aayudh Advance in terms of clinical improvement of various sign and symptoms in mild symptomatic COVID-19 patients. METHOD: Once the patient suffice the requirement of inclusion, exclusion criteria of the study than as per the method of ‘Covariate Adaptive Randomization’ technique, patient was assigned in either Aayudh Advance arm (Test arm) or Control Arm. Here standard of Care treatment was given to all patients of both the arms. Treatment was given for the period of 14 days or till patient turned COVID-19 negative, which ever was earlier. Clinical signs and symptoms viz. body temperature, SpO 2, Scoring of Cough & Scoring of Shortness of breath were recorded on all 5 Clinical visits along with biochemical testing like RT-PCR (with CT value of E gene and RDRP gene), serum ferritin, CRP and NLR observed on weekly Visit. RESULT: Total 74 patients were enrolled in the present study. Out of which 60 patients (30 patients in each group) have completed study as per the protocol, whereas 14 patients have voluntarily withdrawn from the study due to getting early discharge from the hospital. All patients in Aayudh Advance treatment group recovered (100%) after 14 days. This observed recovery was 15.38% more as compared to Standard of Care treatment alone. Further, there was statistically significant reduction (p < 0.05) in viral load as indicated by significant increase in CT value of E-gene and RDRP gene. Further, no patients reported any Adverse Reaction as well as no drug to drug interaction was observed with supplemental treatment with Aayudh Advance. CONCLUSION: The Aayudh Advance was found safe as well as more effective in terms of reduction of viral load. % recovery was more in Treatment arm as compared to Control arm in mild symptomatic COVID-19 patients. Elsevier 2021-03-11 /pmc/articles/PMC7948525/ /pubmed/33728385 http://dx.doi.org/10.1016/j.conctc.2021.100755 Text en © 2021 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Dutt, Jayesh
Ganatra, Bhavdeep
Suthar, Nilay
Malek, Mohammedebrahim
Shukla, Bhakti
Shukla, Krupali
Shukla, Karna
Pandit, Shreya
Rachchh, Manish
Gokani, Rina
Bhalani, Mona
A randomized and comparative study to assess safety and efficacy of supplemental treatment of a herbal formulation - Aayudh Advance comprising essential oils in patients with corona virus 2019 (COVID-19)
title A randomized and comparative study to assess safety and efficacy of supplemental treatment of a herbal formulation - Aayudh Advance comprising essential oils in patients with corona virus 2019 (COVID-19)
title_full A randomized and comparative study to assess safety and efficacy of supplemental treatment of a herbal formulation - Aayudh Advance comprising essential oils in patients with corona virus 2019 (COVID-19)
title_fullStr A randomized and comparative study to assess safety and efficacy of supplemental treatment of a herbal formulation - Aayudh Advance comprising essential oils in patients with corona virus 2019 (COVID-19)
title_full_unstemmed A randomized and comparative study to assess safety and efficacy of supplemental treatment of a herbal formulation - Aayudh Advance comprising essential oils in patients with corona virus 2019 (COVID-19)
title_short A randomized and comparative study to assess safety and efficacy of supplemental treatment of a herbal formulation - Aayudh Advance comprising essential oils in patients with corona virus 2019 (COVID-19)
title_sort randomized and comparative study to assess safety and efficacy of supplemental treatment of a herbal formulation - aayudh advance comprising essential oils in patients with corona virus 2019 (covid-19)
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948525/
https://www.ncbi.nlm.nih.gov/pubmed/33728385
http://dx.doi.org/10.1016/j.conctc.2021.100755
work_keys_str_mv AT duttjayesh arandomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT ganatrabhavdeep arandomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT sutharnilay arandomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT malekmohammedebrahim arandomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT shuklabhakti arandomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT shuklakrupali arandomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT shuklakarna arandomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT panditshreya arandomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT rachchhmanish arandomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT gokanirina arandomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT bhalanimona arandomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT duttjayesh randomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT ganatrabhavdeep randomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT sutharnilay randomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT malekmohammedebrahim randomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT shuklabhakti randomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT shuklakrupali randomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT shuklakarna randomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT panditshreya randomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT rachchhmanish randomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT gokanirina randomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19
AT bhalanimona randomizedandcomparativestudytoassesssafetyandefficacyofsupplementaltreatmentofaherbalformulationaayudhadvancecomprisingessentialoilsinpatientswithcoronavirus2019covid19